Dopamine agonist withdrawal syndrome and non-motor symptoms after Parkinson's disease surgery
Author(s) -
Melissa J. Nirenberg
Publication year - 2010
Publication title -
brain
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.142
H-Index - 336
eISSN - 1460-2156
pISSN - 0006-8950
DOI - 10.1093/brain/awq165
Subject(s) - parkinson's disease , dopamine agonist , dopamine , medicine , agonist , motor symptoms , anesthesia , disease , dopaminergic , receptor
ARTICLESir, I read with interest the manuscript by Dr Thobois and colleagues (Thobois et al. , 2010), in which the authors report the occurrence of depression and apathy after deep brain stimulation surgery for Parkinson’s disease and correlate these symptoms with mesolimbic dopaminergic denervation on neuroimaging studies. I agree with the authors’ interpretation of post-surgical apathy as a drug withdrawal state precipitated by the rapid tapering of dopaminergic medications (Rabinak and Nirenberg, 2010). My strong suspicion, however, is that severe non-motor symptoms that occur after deep brain stimulation are largely attributable to dopamine agonist withdrawal syndrome (DAWS) rather than a non-specific dopamine withdrawal state (Rabinak and Nirenberg, 2010). Furthermore, I have significant safety concerns about the use of piribedil as a treatment for these withdrawal symptoms.Recognition of DAWS is critical because it: (i) exclusively occurs in patients with baseline dopamine agonist-related impulse control disorders; (ii) responds only to dopamine agonist repletion and not to levodopa or other Parkinson’s disease medications; and (iii) includes not only apathy and depression, but also a broad …
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom